© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at kkahl@mjhlifesciences.com.
January 30, 2024
Article
Patients with high-risk prostate cancer who had a higher dose of radiation plus long-term androgen deprivation therapy tended to live longer than those who had a lower dose.
January 21, 2024
Article
Keytrida plus Lenvima improved survival and duration of response in patients with advanced hepatocellular carcinoma.
December 19, 2023
Article
A nurse practitioner talks about personalized therapy and the role that genomic testing plays for patients with breast cancer.
December 12, 2023
Article
Study findings support the use of a financial navigation program, in hopes of aiding patients with multiple myeloma affected by financial toxicity.